Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclobenzaprine and ethanol interaction.

F S Messiha, C D Barnes

    Pharmacology, Biochemistry, and Behavior
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Cyclobenzaprine, a muscle relaxant, intensifies ethanol

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ionization-induced electron trapping in ultrarelativistic plasma wakes.

    Physical review letters·2007
    Same author

    Positron production by x rays emitted by betatron motion in a plasma wiggler.

    Physical review letters·2006
    Same author

    Hose instability and wake generation by an intense electron beam in a self-ionized gas.

    Physical review letters·2006
    Same author

    Multi-GeV energy gain in a plasma-wakefield accelerator.

    Physical review letters·2005
    Same author

    Plasma wakefield acceleration in self-ionized gas or plasmas.

    Physical review. E, Statistical, nonlinear, and soft matter physics·2003
    Same author

    Cholinergic neurons of the dorsal pontine tegmentum projecting to the cerebellar vermal cortex of the kitten.

    Archives italiennes de biologie·1998
    Same journal

    Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Modulation of prefrontal NMDA receptors reveals pharmacogenetic differences between SHR and SLA16 rat strains.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Spontaneous oxycodone withdrawal alters behavior and oligodendrocyte-related gene expression in mice.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Improvement in depressive symptoms in people undergoing cognitive behavioral therapy who supplemented with probiotics: An open-label, pilot study.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Long-term follow-up of children with autism spectrum disorder and severe treatment-resistant behavioral symptoms treated with purified cannabidiol.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease.

    Pharmacology, biochemistry, and behavior·2026
    See all related articles

    Area of Science:

    • Pharmacology and Toxicology
    • Neuroscience
    • Biochemistry

    Background:

    • Cyclobenzaprine is a tricyclic compound used as a muscle relaxant.
    • Ethanol (alcohol) is a central nervous system depressant with significant metabolic pathways.
    • Interactions between ethanol and other centrally acting drugs can lead to unpredictable effects.

    Purpose of the Study:

    • To investigate the effects of cyclobenzaprine on ethanol's central depressant actions.
    • To examine cyclobenzaprine's impact on key hepatic enzymes involved in ethanol metabolism.

    Main Methods:

    • Rodent models (mice and rats) were used for in vivo and in vitro studies.
    • Cyclobenzaprine was administered prior to ethanol to assess behavioral effects (narcosis).
    • In vitro assays measured the inhibition of alcohol dehydrogenase and aldehyde dehydrogenase by cyclobenzaprine.

    Related Experiment Videos

    Main Results:

    • Cyclobenzaprine significantly enhanced ethanol-induced narcosis in mice, with a more pronounced effect in males.
    • In vitro, cyclobenzaprine inhibited rat liver alcohol dehydrogenase activity within a specific concentration range.
    • Cyclobenzaprine showed minimal effect on hepatic aldehyde dehydrogenase activity in vitro.

    Conclusions:

    • Cyclobenzaprine exhibits central depressant properties that potentiate ethanol's effects.
    • Inhibition of liver alcohol dehydrogenase by cyclobenzaprine may contribute to the observed potentiation of ethanol's effects.
    • Tricyclic compounds like cyclobenzaprine may interact with ethanol metabolism, potentially influencing toxicity.